HIV+Hep in the News

Trump’s 2019 HIV initiative on list of programs for possible freeze

The Ending the HIV Epidemic program could be taken away. Jeremiah Johnson said while it is uncertain what exactly is happening, PrEP4All is concerned about possible disruptions in care. So is Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, who said in a statement to Inside Health Policy that pausing the programs would have health implications. “This is extremely disconcerting. This money has already been appropriated by Congress. People with HIV/AIDS depend on medications, health care and support services for the rest of their lives and as a nation we have to take steps to prevent HIV every day, we just can’t pause these programs or stop funding them,” Schmid said. “These are lifesaving programs and HIV is an infectious disease with serious health consequences if not properly addressed–we must continue to fund them.”

read more

Trump’s federal assistance ‘pause’: Judge delays order, states confirm Medicaid portal disruptions

“This is extremely disconcerting,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, in an emailed statement. “People with HIV/AIDS depend on medications, healthcare and support services for the rest of their lives and we have to take steps to prevent HIV every day, we just can’t stop funding these programs. These lifesaving programs serve a wide array of different populations, and HIV is an infectious disease with serious health consequences if not properly addressed—we can’t overlook any community and must serve everyone.”

read more

Copay assistance is not going towards patient deductibles thus leaving people with out-of-pocket costs

In a previous interview with Contagion, Carl Schmid, executive director of the HIV+Hepatitis Policy Institute discussed the federal courts 2022 decision on copay assistance, and the Biden administration’s decision to not enforce the court’s ruling. “I guess they’re getting pressure from the big insurers and the big PBMs. And you know what I’m hearing is that the insurers are saying this leads to higher drug prices. And you know, the Biden administration has really prided itself on taking on Big Pharma and lowering drug prices. Well, this is the perfect example to lower drug prices. And I don’t think they understand it,” Schmid said.

read more

Pin It on Pinterest

Share This